Clinical Trial Update: Conditioning Regimen of Bendamustine and Melphalan Followed by Transplant in Patients With Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study evaluating a conditioning regimen of bendamustine and melphalan followed by transplant in patients with multiple myeloma; study completed with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bendamustine (Bendamustine)
• Melphalan (Melphalan)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-06-04